MRI connectome predicts gray matter atrophy progression in early Parkinson’s disease

FHS
June 25, 2024
3:25 pm

The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson’s disease, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Merck’s 21-valent pneumococcal vaccine for adults wins FDA approval

Merck’s 21-valent pneumococcal vaccine was approved by the FDA on Monday, bringing a new competitor to market for Pfizer’s 20-valent product. Merck’s vaccine, called Capvaxive

June 18, 2024

Psilocybin’s Impact on Brain Activity | Psychedelic Invest

Psilocybin, the primary psychoactive compound found in hallucinogenic mushrooms, has long intrigued scientists and enthusiasts alike for its profound effects on perception and consciousness. Recent

July 23, 2024

Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus,

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.